Company to buy
- Size: Small
- Revenue: 2 – 10 million EUR
- Target location: Europe.
- Reason for acquisition: The company wants to expand in Europe
- #CFIE PHB072
Overview of clinical operations and monitoring company wanted
This buyer is looking for a new acquisition in Europe to expand their operations in Europe. Specifically, the company wants to acquire a clinical operations and monitoring company in Europe.
Profile (strategy) of buyer for clinical operations and monitoring company
The company is a full-service international CRO managing clinical trials since 1984. Primarily, they specialize in drug, biologic, device, diagnostics, and consumer products based in the USA. Further, the company is focused on complex areas of clinical development. This includes oncology-hematology, infectious diseases, critical care, and CNS in both adult and pediatric populations. Moreover, the firm has more than 80 approved drugs and has a global presence.
Contact us to get details about this buyer for a clinical operations & monitoring company in europe
Activities and products of the target clinical operations and monitoring company
- The buyer is now looking for a clinical operations and monitoring company in Europe
- The goal of the buyer is to acquire a profitable company with revenue in the range of 2 to 10 million euros
Highlights of the buyer for clinical operations and monitoring company
- Global presence
- Phases 1-4, diagnostics and devices
- Focused on complex areas of clinical development
More information on this buyer for a clinical operations and monitoring company in Europe
Please get in touch if you are interested in learning more about this buyer for a clinical operations and monitoring company in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.